Effect of SGLT2-Inhibitors on Epicardial Adipose Tissue: A Meta-Analysis

(1) Sodium–glucose cotransporter-2 inhibitors (SGLT2-i) reduce adipose tissue and cardiovascular events in patients with type 2 diabetes (T2D). Accumulation of epicardial adipose tissue (EAT) is associated with increased cardio-metabolic risks and obstructive coronary disease events in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Masson, Walter, Lavalle-Cobo, Augusto, Nogueira, Juan Patricio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391573/
https://www.ncbi.nlm.nih.gov/pubmed/34440918
http://dx.doi.org/10.3390/cells10082150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391573/
https://www.ncbi.nlm.nih.gov/pubmed/34440918
http://dx.doi.org/10.3390/cells10082150

Ejemplares similares